BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 29234201)

  • 1. Acute and Chronic Rejection After Liver Transplantation: What A Clinician Needs to Know.
    Choudhary NS; Saigal S; Bansal RK; Saraf N; Gautam D; Soin AS
    J Clin Exp Hepatol; 2017 Dec; 7(4):358-366. PubMed ID: 29234201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Revisiting chronic rejection following living donor liver transplantation in the tacrolimus era: A single center experience.
    Choudhary NS; Saraf N; Saigal S; Gautam D; Rastogi A; Goja S; Bhangui P; Srinivasan T; Yadav SK; Soin A
    Clin Transplant; 2018 Feb; 32(2):. PubMed ID: 29160909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intestine and multivisceral transplantation in the United States: a report of 20-year national registry data (1990-2009).
    Cai J
    Clin Transpl; 2009; ():83-101. PubMed ID: 20524278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mortality after steroid-resistant acute cellular rejection and chronic rejection episodes in adult intestinal transplants: report from a single center in induction/preconditioning era.
    Lauro A; Bagni A; Zanfi C; Pellegrini S; Dazzi A; Del Gaudio M; Ravaioli M; Di Simone M; Ramacciato G; Pironi L; Pinna AD
    Transplant Proc; 2013 Jun; 45(5):2032-3. PubMed ID: 23769102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Durable Clinical and Immunologic Advantage of Living Donor Liver Transplantation in Children.
    Przybyszewski EM; Verna EC; Lobritto SJ; Martinez M; Vittorio JM; Fox AN; Samstein B; Kato T; Griesemer AD; Emond JC
    Transplantation; 2018 Jun; 102(6):953-960. PubMed ID: 29369249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex mismatch as a risk factor for chronic rejection of liver allografts.
    Candinas D; Gunson BK; Nightingale P; Hubscher S; McMaster P; Neuberger JM
    Lancet; 1995 Oct; 346(8983):1117-21. PubMed ID: 7475600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Donor-Specific Antibodies in Intestinal Transplantation: Experience at the University of California Los Angeles and Literature Review.
    Cheng EY; Kaneku H; Farmer DG
    Clin Transpl; 2014; ():153-9. PubMed ID: 26281140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of children undergoing cardiac transplantation with high Panel Reactive Antibodies.
    Asante-Korang A; Jacobs JP; Ringewald J; Carapellucci J; Rosenberg K; McKenna D; McCormack J; Wilmot I; Gjeldum A; Lopez-Cepero M; Sleasman J
    Cardiol Young; 2011 Dec; 21 Suppl 2():124-32. PubMed ID: 22152539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Marked Differences in acute cellular rejection rates between living-donor and deceased-donor liver transplant recipients.
    Liu LU; Bodian CA; Gondolesi GE; Schwartz ME; Emre S; Roayaie S; Schiano TD
    Transplantation; 2005 Oct; 80(8):1072-80. PubMed ID: 16278588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for acute liver allograft rejection and their influences on treatment outcomes of rescue therapy in living donor liver transplantation.
    Shindoh J; Akamatsu N; Tanaka T; Kaneko J; Tamura S; Sakamoto Y; Hasegawa K; Sugawara Y; Makuuchi M; Kokudo N
    Clin Transplant; 2016 Aug; 30(8):880-5. PubMed ID: 27146588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Living related liver transplantation: histopathologic analysis of graft dysfunction in 304 patients.
    Minamiguchi S; Sakurai T; Fujita S; Okuno T; Haga H; Mino M; Kanehira K; Matsushiro H; Nakashima Y; Inomata Y; Tanaka K; Yamabe H
    Hum Pathol; 1999 Dec; 30(12):1479-87. PubMed ID: 10667427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. De novo autoimmune hepatitis -is this different in adults compared to children?
    Kerkar N; Vergani D
    J Autoimmun; 2018 Dec; 95():26-33. PubMed ID: 30396746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of donor-recipient genetic relationship on outcome of living donor liver transplantation.
    Ali MA; Elshobari MM; Salah T; Kandeel AR; Sultan AM; Elghawalby AN; Shehta A; Elsayed U; Fathy O; Yassen A; Wahab MA
    Liver Transpl; 2017 Jan; 23(1):43-49. PubMed ID: 27516392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential immunological advantage of intravenous mycophenolate mofetil with tacrolimus and steroids in primary deceased donor liver transplantation and live donor liver transplantation without antibody induction.
    Jain A; Sharma R; Ryan C; Tsoulfas G; Orloff M; Abt P; Kashyap R; Batzold P; Sauberman L; Safadjou S; Graham M; Bozorgzadeh A
    Liver Transpl; 2008 Feb; 14(2):202-9. PubMed ID: 18236395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Graft and patient survival after adult live donor liver transplantation compared to a matched cohort who received a deceased donor transplantation.
    Thuluvath PJ; Yoo HY
    Liver Transpl; 2004 Oct; 10(10):1263-8. PubMed ID: 15376301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of immunosuppression and acute rejection on recurrence of hepatitis C: results of the National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database.
    Charlton M; Seaberg E
    Liver Transpl Surg; 1999 Jul; 5(4 Suppl 1):S107-14. PubMed ID: 10431024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complete immunosuppression withdrawal and subsequent allograft function among pediatric recipients of parental living donor liver transplants.
    Feng S; Ekong UD; Lobritto SJ; Demetris AJ; Roberts JP; Rosenthal P; Alonso EM; Philogene MC; Ikle D; Poole KM; Bridges ND; Turka LA; Tchao NK
    JAMA; 2012 Jan; 307(3):283-93. PubMed ID: 22253395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes in hepatitis C virus-infected recipients of living donor vs. deceased donor liver transplantation.
    Terrault NA; Shiffman ML; Lok AS; Saab S; Tong L; Brown RS; Everson GT; Reddy KR; Fair JH; Kulik LM; Pruett TL; Seeff LB;
    Liver Transpl; 2007 Jan; 13(1):122-9. PubMed ID: 17192908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention and restoration of second-set liver allograft rejection in presensitized mice: the role of "passenger" leukocytes, donor major histocompatibility complex antigens, and host cytotoxic effector mechanisms.
    Fu F; Li W; Lu L; Thomson AW; Fung JJ; Qian S
    Transplantation; 1999 Feb; 67(3):444-50. PubMed ID: 10030293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic rejection after liver transplantation: Opening the Pandora's box.
    Angelico R; Sensi B; Manzia TM; Tisone G; Grassi G; Signorello A; Milana M; Lenci I; Baiocchi L
    World J Gastroenterol; 2021 Dec; 27(45):7771-7783. PubMed ID: 34963740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.